Attached files
| file | filename |
|---|---|
| S-1 - FORM S-1 - UNIGENE LABORATORIES INC | unigene_s1-101912.htm |
| EX-5.1 - EXHIBIT 5.1 - UNIGENE LABORATORIES INC | ex5-1.htm |
| EX-23.3 - EXHIBIT 23.3 - UNIGENE LABORATORIES INC | ex23-3.htm |
| EX-23.2 - EXHIBIT 23.2 - UNIGENE LABORATORIES INC | ex23-2.htm |
| EX-10.91 - EXHIBIT 10.91 - UNIGENE LABORATORIES INC | ex10-91.htm |
Exhibit 10.110
| CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE |
THIS CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE (the “Separation Agreement”) is made and entered into by and between Jenene Thomas (“Employee”) and Unigene Laboratories, Inc. (“Unigene” or the “Company”).
RECITALS
WHEREAS, Employee has been notified that the Company has decided to terminate her employment, effective September 28, 2012; and
WHEREAS, Unigene and Employee wish to confirm the terms of Employee’s separation from employment, and to settle, release and discharge with prejudice, any and all claims, causes of action or disputes Employee has or may have against any of the Released Parties (defined in Paragraph 3(a) below), including but not limited to those arising and/or which may be arising out of her employment with the Company and her separation from that employment.
NOW, THEREFORE, Unigene and Employee understand and agree as follows:
1. Separation of Employment.
(a) Employee acknowledges that she will be completely separated from Unigene and her employment ended as of September 28, 2012 (the “Separation Date”). Except as expressly provided by this Separation Agreement or otherwise required by law, any and all duties or obligations of Unigene pursuant to Employee’s employment and/or separation from that employment, whether by written agreement or otherwise, will be and are completely extinguished as of her Separation Date.
(b) Likewise, all of Employee’s duties and obligations to Unigene will be and are extinguished as of her Separation Date, except as otherwise provided by law.
2. Acknowledgment of Receipt of Previous Pay and Benefits; Payment of Allowable Business Expenses; No Other Amounts Due and Owing.
(a) Employee represents and warrants that she has reported to Unigene all of her hours worked as of her Separation Date. She further acknowledges, understands and agrees that, as of the date she executes this Separation Agreement, she has: (i) been paid and received full compensation, less all applicable federal, state and local employment and income taxes and other required or elected withholdings, for all accrued wages and other earnings due to her in connection with her work for the Company; and (ii) been paid in full, at her regular base salary rate, for all accrued, unused vacation days existing under any Unigene policy or practice in her vacation bank as of her Separation Date (a total of eighteen (18) days) the total gross amount of sixteen thousand, forty four 23/100 Dollars $16,044.23.
(b) Employee understands that she will receive payment for all reimbursable travel and other reasonable business expenses under Unigene’s polices or practices, provided that she submits appropriate, written vouchers and receipts for the same to the Company no later than September 30, 2012. All such reimbursements shall be made promptly and in all events no later than the end of the taxable year following the year in which the expense was incurred.
(c) Employee represents and warrants that she has incurred no work-related injuries and, to the best of her knowledge, has contracted no known occupational diseases. She acknowledges and agrees that she has previously been provided all family, medical and disability leave and other benefits to which she was ever entitled under federal, state or local family or medical leave and disability accommodations laws, including any rights to reinstatement upon the conclusion of any period of leave, if any.
(d) Unigene will accelerate the vesting of the Employee’s non-vested stock options, effective September 28, 2012. The exercise period of the Employee’s vested stock options will terminate September 27, 2013, at which point the stock options will expire.
(e) Employee understands, acknowledges and agrees that except as provided in this Separation Agreement, she will not be entitled to any payment or other benefit from the Released Parties, and the Released Parties shall never be required to make any further payment or provide any further benefit, for any reason whatsoever, to her or any person regarding any claim, right or status she may have arising on or before the Effective Date of this Separation Agreement (as defined in Paragraph 16(f), below).
3. Release of Claims and Covenant Not to Sue.
(a) In exchange for Unigene providing Employee with the payments and other benefits described within this Separation Agreement, Employee on behalf of himself, her heirs, executors, personal representatives, administrators, agents and assigns, forever waives, releases, gives up and discharges all waivable claims against Unigene, its parent, subsidiaries, and other related or affiliated corporations, their employee benefit plans and trustees, fiduciaries, administrators and parties-in-interest of those plans, and all of their past and present employees, managers, directors, officers, administrators, shareholders, members, agents, attorneys, insurers, re-insurers and contractors acting in any capacity whatsoever, and all of their respective predecessors, heirs, personal representatives, successors and assigns (collectively, the “Released Parties” as used throughout this Separation Agreement), whether accrued or unaccrued, liquidated or contingent, and now known or unknown, based on, related to, or arising from any event that has occurred before she signs this Separation Agreement and based upon, related to or arising out of or concerning her employment with Unigene, the termination of her employment by Unigene, the terms, benefits and attributes of her employment with Unigene, and any and all violations and/or alleged violations of federal, state or local fair employment practices or laws by any of the Released Parties for any reason and under any legal theory whatsoever including but not limited to the Title VII of the Civil Rights Act of 1964, 42 U.S.C. 2000(e), et seq. (“Title VII”), the Age Discrimination in Employment Act, 29 U.S.C. § 621, et seq. (“ADEA”), the Older Workers Benefit Protection Act, 29 U.S.C. § 626(f), et seq. (“OWBPA”), the Americans With Disabilities Act, 42 U.S.C. §12101, et seq. (“ADA”), the Worker Adjustment and Retraining Notification Act, 29 U.S.C. § 2101, et seq. (“WARN”), the Occupational Safety and Health Act, 29 U.S.C. 651, et seq. (“OSHA”), the Civil Rights Act of 1991, 42 U.S.C. §§ 1981, 1983, 1985, 1986 and 1988, the Lilly Ledbetter Fair Pay Act of 2009, H.R. 11 (“Fair Pay Act”), the Fair Credit Reporting Act, 15 U.S.C. 1681, et seq. (“FCRA”), the Family and Medical Leave Act, 29 U.S.C. § 2601, et seq. (“FMLA”), the Employee Retirement Income Security Act of 1974, as amended, 29 U.S.C. 1001, et seq. (“ERISA”), the Equal Pay Act of 1963, as amended, 29 U.S.C. § 206, et seq. (“EPA”), the Consolidated Omnibus Budget Reconciliation Act, 29 U.S.C. § 1161, et seq. (“COBRA”), the retaliation provisions of the Fair Labor Standards Act, 29 U.S.C. § 215(a)(3), et seq. (“FLSA”), the New Jersey Discrimination in Wages Law, N.J.S.A. 34:11-56.2, et seq., the New Jersey Law Against Discrimination, N.J.S.A. 10:5-12, et seq. (“NJLAD”), the New Jersey Family Leave Act, N.J.S.A. 34:11B-1, et seq. (“NJFLA”), the New Jersey Temporary Disability Benefits and Family Leave Insurance Law, N.J.S.A. 43:21-25, et seq., the New Jersey Civil Rights Act, N.J.S.A. 10:6-1, et seq. (“NJCRA”), the New Jersey Fair Credit Reporting Act, N.J.S.A. 56:-28, et seq. (“NJFCRA”), the New Jersey Conscientious Employee Protection Act, N.J.S.A. 34:19-1, et seq. (“CEPA”), the New Jersey Millville Dallas Airmotive Plant Job Loss Act, N.J.S.A. 34:21-1, et seq., the retaliation provisions of the New Jersey Wage and Hour Law, N.J.S.A. 34:11-56a, et seq., the retaliation provisions of the New Jersey Workers’ Compensation Act, N.J.S.A. 34:15-1, et seq., and all other federal, state and local regulations, rules, ordinances or orders, as they may be amended. She also forever waives, releases, discharges and gives up all claims, whether accrued or unaccrued, liquidated or contingent, real or perceived, and known or unknown, and all claims for breach of implied or express contract, breach of promise, breach of the covenant of good faith and fair dealing, misrepresentation, negligence, fraud, estoppel, defamation, intentional infliction of emotional distress, violation of public policy, wrongful, retaliatory or constructive discharge, or any other claim or tort arising under any federal, state, or local law, regulation, ordinance or judicial decision and/or under the United States and New Jersey Constitutions.
(b) Employee understands that the laws described above give her important remedies that relate to claims that she has or may have arising out of or in connection with her employment and/or separation from employment with Unigene and acknowledges and agrees that she freely and voluntarily give up those remedies and claims. By signing this Separation Agreement, she also acknowledges and agrees that her waivers and releases expressly include a waiver of all claims existing on or before the Effective Date of this Separation Agreement which she knows about and those claims which she may not know about, and specifically includes an unconditional waiver of the right to proceed with any discovery concerning any such claim in any future litigation with any Released Party, if any. Further, Employee understands, acknowledges and agrees that her waivers and releases under this Separation Agreement include any and all claims for attorneys’ fees or other fees or costs incurred for any reason.
2
(c) Employee warrants that she does not have any complaint, charge or grievance against any Released Party pending before any federal, state or local court or administrative agency or arbitration panel. She further agrees not to file a lawsuit against any of the Released Parties in any court of the United States or any state or local governmental subdivision thereof, or with any arbitration panel, concerning any claim, demand, issue or cause of action covered by this Separation Agreement. Should Employee file a lawsuit with any court or arbitration panel concerning any claim, demand, issue or cause of action waived through this Separation Agreement and not specifically excluded as described in Section 4 and its subparagraphs below, she agrees that she will be responsible to pay the legal fees and costs incurred by the Released Parties in defending any claims which are determined to be barred by this Separation Agreement. Further, she agrees that nothing in this Separation Agreement shall limit the right of a court, tribunal or arbitration panel to determine, in its sole discretion, that the Released Parties are entitled to restitution, recoupment or set off of any monies paid to her under this Separation Agreement should the release of any claims in this Separation Agreement subsequently be found to be invalid.
4. Exclusions from Release of Claims and Covenant Not to Sue.
(a) Employee understands and agrees that nothing in this Separation Agreement limits her right to bring an action to enforce the terms of this Separation Agreement.
(b) Employee understands and agrees that the Release contained in Section 3 and its subparagraphs above does not include a waiver of any claims which cannot be waived by law, or any accrued, vested rights she may have in any existing Company tax-qualified retirement plan or other benefit plans in accordance with the terms of such plans and applicable law. Furthermore, she understands that nothing in this Separation Agreement will preclude her from purchasing continuation health benefits coverage under the Company’s group healthcare plans, to the extent she is otherwise eligible and for the period provided by law under COBRA and/or any similar state law and that she will be provided with continuation health benefits coverage information under separate cover letter following her Separation Date.
(c) Employee understands and agrees that this Separation Agreement does not limit her right to bring an action to contest the validity of the release she has signed under the ADEA or the OWBPA.
(d) Employee understands and agrees that nothing in this Separation Agreement prevents her from filing, cooperating with, or participating in any proceeding before the United States Equal Employment Opportunity Commission (“EEOC”) or any similar state or local fair employment practices agency. However, Employee expressly waives her right to any individual monetary award, injunctive relief, or other recovery should any federal, state or local administrative agency pursue any claims on her behalf arising out of or relating to her employment with and/or separation from employment from any Released Party. This means that by signing this Separation Agreement, Employee will have waived any right she had to bring a lawsuit or obtain an individual recovery if an administrative agency pursues a claim against any of the Released Parties based on any actions taken by any of them up to the date she signs this Separation Agreement and, should she be awarded money damages or any other remuneration or relief, she hereby unconditionally assigns to the Company any right or interest she may have to receive the same.
(e) Employee understands and agrees that nothing in this Separation Agreement prohibits her from filing a claim to collect any benefits available to her under the New Jersey Unemployment Compensation Law, or from collecting any award of benefits granted to her in accordance with that law, following her Separation Date.
5. Non-Admission of Liability.
Employee acknowledges and agrees that this Separation Agreement shall not in any way be construed as an admission that any of the Released Parties owe her any money or have acted wrongfully, unlawfully, or unfairly in any way towards her. In fact, Employee understands that the Released Parties specifically deny that they have violated any federal, state or local law or ordinance, or any right or obligation that they owe or might have owed to her at any time, and maintain that they have at all times treated her in a fair, lawful, non-discriminatory and non-retaliatory manner.
3
|
|
6.
|
Payments and Other Benefits to be Provided to Employee in Exchange for her Release.
|
(a) In exchange for and in consideration of Employee’s promises set forth in this Separation Agreement, and contingent upon Unigene’s receipt of a signed, unrevoked and effective original of this Separation Agreement in accordance with the provisions of Section 16 below, Unigene agrees to provide the following payments and other benefits to Employee on behalf of all Released Parties:
(i) Unigene will pay Employee the total gross amount of seventy seven thousand two hundred fifty dollars ($77,250.00), which amount is the equivalent of four (4) months of Employee’s base salary in effect as of her Separation Date (the “Severance Amount”). The Severance Amount, and Employee’s regular salary for the period August 13, 2012 through September 28, 2012, in the amount of thirty two thousand six hundred eighty two and 69/100 Dollars ($32,682.69) shall be paid in a lump sum payment immediately following the execution of the Separation Agreement and the seven (7) day revocation period.
(ii) To the extent Employee is eligible for and has elected COBRA continuation coverage in accordance with Unigene’s COBRA continuation health coverage policies, Unigene will pay Employee’s full monthly premiums due to purchase COBRA continuation health coverage through February of 2013, subject to all required taxes, tax withholdings and other applicable deductions (the “COBRA Subsidy” during the “COBRA Subsidy Period”).
(1) Notwithstanding the foregoing, Unigene has and will have no obligation to make any payments toward COBRA continuation health coverage for Employee and her dependents extending beyond the COBRA Subsidy Period.
(2) Employee acknowledges and agrees that the Company’s COBRA Subsidy during the COBRA Subsidy Period will not extend her and/or her eligible dependents’ eligibility for continuation health coverage under COBRA and agrees to hold harmless the Released Parties from any and all claims arising directly or indirectly from the COBRA Subsidy referenced above with the sole exception of claims arising from any failure by the Company to pay the COBRA Subsidy.
(3) Employee understands and agrees that, after expiration of the COBRA Subsidy Period, she and her eligible dependents will be able to continue to receive the COBRA continuation health coverage for the remainder of the applicable COBRA continuation period permitted by law provided that they remain eligible for and pay the full cost of such coverage in accordance with Unigene’s COBRA continuation health coverage policies; and
(b) Employee acknowledges that the Severance Amount, the COBRA Subsidy, and the vesting of the stock options afforded to her through this Separation Agreement constitutes good and adequate consideration in exchange for her promises and releases herein and is in addition to anything of value to which she is presently entitled by virtue of any understandings, agreements or contracts between her and any of the Released Parties, her employment with Unigene and her separation from that employment, and any of the Released Parties’ policies, practices, plans or prior understandings with her including but not limited to compensation, vacation, bonus, severance, on-call, paid time off, commission agreements, incentive compensation plans, equity incentives, stock options, offer letters, employment agreements, or any other fringe benefit plans or policies.
7. No Reliance upon Verbal Representations.
Employee represents, acknowledges and agrees that no promises, statements or inducements have been made which caused her to sign this Separation Agreement other than those expressly stated in writing within this Separation Agreement.
4
8. Reference-Related Communications.
(a) Employee agrees that, should she or any prospective employer desire that Unigene engage in any reference-related communications, she will direct such inquiries exclusively to Unigene’s Human Resources Department, for confirmation only of her: (i) dates of employment; (ii) employment position; and (iii) base salary.
(b) Except with regard to verbal confirmation of her dates of employment, employment position, and base salary by Unigene as expressly set forth above, Employee agrees that the Released Parties will have no obligation to engage in any reference-related communications whatsoever with her past, existing or prospective employers unless compelled by a court order or other legal process.
(c) Notwithstanding the foregoing, Employee understands and agrees that the Released Parties will remain free to internally communicate, to those with a business need to know, any and all information concerning her employment history with the Company.
9. Confidentiality of this Separation Agreement.
(a) Employee agrees to keep the fact, terms and amount of this Separation Agreement completely confidential, and not to disclose such information to anyone other than to her spouse, civil union or legal domestic partner, her attorneys, and her licensed tax and/or professional investment advisors (collectively, Employee’s “Confidants”), all of whom must first be informed by her of, and agree to be bound by, this confidentiality provision. Neither Employee nor her Confidants shall disclose the fact, amount or terms of this Separation Agreement to anyone including, but not limited to, any representative of any print, radio or television media; any past, present or prospective employee of or applicant for employment with the Company; any executive recruiter or “headhunter”; any counsel for any current or former employee of the Company; any other counsel or third party; or the public at large. Employee acknowledges and agrees that any breach of this provision by her Confidants shall be treated as if she himself disclosed the information and breached this Separation Agreement.
(b) Should Employee or her Confidants receive or hereinafter be subjected to a subpoena, court order or other compulsory process seeking to compel the disclosure of any of the information described in this Separation Agreement or any other confidential or proprietary business information belonging to the Company, or be requested for the disclosure of same pursuant to an investigation conducted by a governmental agency, Employee shall immediately, within forty-eight (48) hours upon receipt of such process or request, notify Unigene’s General Counsel, in writing, and consent to the Released Parties’ immediate intervention in the matter. Notwithstanding the foregoing, nothing contained in this Separation Agreement shall preclude Employee from discussing any matter concerning the Company with any governmental regulatory or self-regulatory agency. Furthermore, Employee agrees that she will cooperate with any governmental regulatory or self-regulatory agency that requests her to provide testimony or information regarding the Company; however her cooperation may not include disclosing the terms of this Separation Agreement. If Employee is compelled to testify by a validly served subpoena or other compulsory process in any legal proceeding or by regulatory authority, she will testify truthfully as to all matters concerning the Company.
5
|
|
10.
|
Continuing Obligation Not to Use Any Confidential Information; and Return of All Confidential Information and Other Company Property.
|
(a) Employee acknowledge and agree that all confidential and proprietary business information (the “Confidential Information”) belonging to the Company and/or the Released Parties, whether in tangible form or otherwise, including all documents and records, whether printed, typed, handwritten, videotaped, transmitted or transcribed on data files or on any other type of media, and whether or not labeled or identified as confidential and proprietary, made or compiled by her or made available to her during the period of her employment with the Company, is and remains the sole property of the Company and the Released Parties. As used in this Agreement, “Confidential Information” means, without limitation, all critical business information such as drug products in development, business models, business strategies, product launch plans, CRO relationships, regulatory submissions, technology used by, or the therapeutic focus of, the Company, as well as all clinical, methodologies, standard operating procedures, and technology used by the Company, the therapeutic focus of the Company and strategic and business models, as well as all marketing and certain financial information, valuations, budgets, internal policies and procedures, organization, business plans, analyses, forecasts, billing practices, pricing information and strategies, service offering strategies, marketing plans and ideas, the identities or other information about customers, customer lists, suppliers and business partners (current and prospective), the terms of current and pending deals, sales data, and sales projections, research, research proposals, unpublished results and reports, and contact and other information regarding suppliers, vendors and consultants. “Confidential Information” also includes all tangible and intangible property of the Company, its licensors, customers or clients, including intellectual property of the Company related to its products, business or services, which is known, used or disclosed to Employee as a consequence of employment by the Company or discovered or developed by Employee during her employment by the Company, including, but not limited to, trade secrets, designs, devices, techniques, sketches, drawings, models, inventions, improvements, ideas, concepts, discoveries, processes, methods of operation, know-how, expressions of ideas and systems, software, software source documents, microcode and source code, routines, sub-routes and algorithms, structure, sequence and organization of computer programs, specifications, and information related to research, development, manufacturing, purchasing, accounting, systems development, marketing, merchandising and selling, and other related data, whether or not patentable or copyrightable. “Confidential Information” does not include information that (i) can be demonstrated by clear and convincing evidence to have already been in Employee’s possession from a source other than the Company, provided that such information was not acquired through any violation of law or other legal obligation, and provided that such information is not subject to another obligation of secrecy, and (ii) becomes generally known to the public or in the industry other than as a result of a disclosure in violation of an obligation to keep such information confidential.
(b) Employee agrees that she has an obligation to and warrants that, as of Unigene’s close of business on her Separation Date, she has returned all originals and all copies of all documents and records made or compiled by her and/or made available to her or provided to her during the period of her employment with Unigene that contain Confidential Information or other business information belonging to the Company and/or any of the Released Parties, whether printed, typed, handwritten, videotaped, transmitted or transcribed on data files or on any other type of media and whether or not labeled or identified as confidential, proprietary or trade secret. Employee further represents and warrants that she has not, and will not, directly or indirectly, at any time, now or ever in the future, download, print, copy, electronically transmit, disclose, release or retain any such information for her own personal use or any other purposes for her own benefit or the benefit of any third party.
(c) In addition to returning all originals and copies (in whatever format) of all Confidential Information and other business information belonging to the Company and/or any of the Released Parties, Employee agrees that she has an obligation to and warrants that she has returned all Unigene property and materials including, but not limited to, credit cards, calling cards, keys, keyfobs, identification badges, files, records, samples, computer disks, laptop computers, printers, personal digital assistants, and cellular telephones.
(d) To the extent that Employee has transferred any Confidential Information or other business information belonging to any of the Released Parties to any personal computer equipment or any other personal electronic storage device, she warrants that she has returned to Unigene true and complete copies of the same and has thereafter fully deleted and otherwise properly disposed of and appropriately removed all electronic copies of the same from her personal computer equipment or other electronic devices in a manner reasonably performed to effectively prevent the disclosure of any sensitive personal data and/or other Confidential Information belonging to the Company.
11. Non-Disparagement.
Employee represents, warrants and agrees that she has not and shall not, now or ever in the future, publicly or privately, make, verbally or in writing, any false, disparaging, derogatory, defamatory, or otherwise inflammatory remarks about any of the Released Parties, or the conduct, operations or financial condition or business practices, policies or procedures of any of the Released Parties or the Company’s management personnel to any third party, and that she has not and will not make or solicit any comments, statements, or the like to the media or to others that may be considered derogatory or detrimental to the good name and business reputation of Unigene, its management personnel, and/or any of the other Released Parties.
6
12. Cooperation.
Employee agrees to cooperate reasonably and in good faith with the Company as may be necessary to respond to any inquiries that may arise with respect to matters that she was responsible for or involved with during her employment with Unigene. She further agrees to cooperate reasonably and in good faith with the Released Parties in connection with any defense, prosecution or investigation concerning any actual or potential litigation or administrative proceeding in which she may be involved or may become involved as a party, non-party or witness.
13. Responsibility for Taxes.
Employee acknowledges and agrees that she has not been provided any advice by any of the Released Parties regarding the tax or withholding consequences of the payments and other benefits provided under this Separation Agreement under any federal, state or local tax or withholding laws or regulations. She further agrees that she will be solely responsible for all of her own tax liabilities and consequences arising under all federal, state or withholding laws or regulations which may result from her receipt of the Severance Amount and the COBRA Subsidy and holds the Released Parties harmless from and indemnifies them for any costs, fines, interest or penalties resulting from such laws or regulations. Additionally, she agrees that the Released Parties shall not be required to pay any further sum to her, even if such tax or withholding consequences are not foreseeable to her at the time she signs this Separation Agreement or are ultimately assessed in a manner which she does not anticipate at the time she signs this Separation Agreement.
14. Successors and Assigns.
This Separation Agreement shall not be assignable by Employee and will be binding upon and inure to the benefit of her and her heirs, administrators, representatives, and executors. This Separation Agreement shall be freely assignable by Unigene without restriction and shall be deemed automatically assigned by the Company with Employee’s consent in the event of any sale, merger, share exchange, consolidation or other business reorganization. This Separation Agreement shall be binding upon, and shall inure to the benefit of, Unigene’s successors and assigns.
|
|
15.
|
Consultation With Counsel; Reasonable Time to Consider Separation Agreement During Review Period; Knowing and Voluntary Acceptance of this Separation Agreement; Right and Time to Revoke; Effective Date.
|
(a) Employee acknowledges that, through this writing, Unigene has advised her to consult with an attorney of her own choosing before signing this Separation Agreement, that the time afforded to her to consider the terms of this Separation Agreement provides her a full and fair opportunity to thoroughly discuss all aspects of her rights and this Separation Agreement with her attorney to the extent she elects to do so, and that she has, in fact, so consulted her attorney or knowingly waived the right to consult her attorney.
(b) Employee warrants that she has carefully read and fully understands all of the terms and provisions contained in this Separation Agreement, she is physically and emotionally competent and of sound mind to execute this Separation Agreement, and she is knowingly and voluntarily signing this Separation Agreement of her own free will, act and deed. She further represents and warrants that she has made such investigation of the facts pertaining to this Separation Agreement and all matters contained herein as she deems necessary, desirable and appropriate, and agrees that the release provided for herein shall remain in all respects effective and enforceable and not subject to termination or rescission by reason of any later discovery of new, different or additional facts.
(c) Employee understands that she has twenty-one (21) calendar days from her receipt of this Separation Agreement to review and consider this Separation Agreement before signing it, except that if the twenty-first (21st) calendar day after she received this Separation Agreement falls on a Saturday, Sunday or holiday observed by Unigene, she shall have until the conclusion of the immediately next business day (the “Review Period”). She further understands that she may use as much of the Review Period as she wishes before signing this Separation Agreement and that she may use all of the Review Period. Employee additionally agrees that any material or immaterial changes to this Separation Agreement will not restart the running of the Review Period.
7
(d) Employee understands that she may elect to accept this Separation Agreement by sending a signed and dated and witnessed original to the attention of Unigene’s Director, Human Resources, postmarked no later than the last day of the Review Period. To the extent that Employee signs this Separation Agreement and returns it to the Company prior to the expiration of the Review Period, she warrants that she has voluntarily and knowingly waived the remainder of the Review Period and that her decision to accept a shortened period of time was not induced by any of the Released Parties through fraud, misrepresentation, a threat to withdraw the offer or alter the offer prior to the expiration of the Review Period, or by providing different terms to workers who sign releases prior the expiration of such periods. If Employee fails to sign this Separation Agreement and return the executed original by the close of business on the last day of the Review Period, this Separation Agreement will be deemed null and void and Employee will not be entitled to receive any of the payments or other benefits offered to her hereunder.
(e) Employee also understands that, following her execution of the Separation Agreement, she will have a period of seven (7) calendar days to revoke this Separation Agreement by delivering written notification of any such revocation to Unigene’s General Counsel no later than the close of business on the seventh (7th) calendar day after she signs it, except that if the seventh (7th) calendar day after she signs the Separation Agreement falls on a Saturday, Sunday or holiday observed by Unigene, she shall have until the conclusion of the immediately next business day (the “Revocation Period”). If Employee revokes this Separation Agreement during the Revocation Period, the Separation Agreement will not be effective and enforceable and she will not be entitled to receive any of the payments or other benefits described in Section 6 and its subparagraphs above.
(f) For purposes of this Separation Agreement, the “Effective Date” as used herein shall mean the first (1st) calendar day after the Revocation Period expires, provided that a notice of revocation has not first been timely served upon the Company by Employee prior to that date.
16. Governing Law and Venue.
This Separation Agreement shall in all respects be interpreted, enforced and governed under the laws of the State of New Jersey, exclusive of any choice of law rules. Any dispute concerning this Separation Agreement shall be brought in, and the parties hereby consent to the personal jurisdiction of, the state and federal courts of the State of New Jersey (to the extent that subject matter jurisdiction exists only).
17. Severability.
Employee agrees that the terms and provisions of this Separation Agreement are severable and shall be deemed to consist of a serious of separate covenants. She further agrees that, should any separate term, covenant, word, clause, phrase, sentence, paragraph or provision of this Separation Agreement be declared or found void, illegal, invalid or unenforceable by a court of competent jurisdiction, the same shall be modified by the court to make it enforceable and/or severed from this Separation Agreement but all other terms, covenants words, clauses, phrases, sentences, paragraphs and provisions shall remain in full force and effect.
18. Proper Construction.
(a) The language of all parts of this Separation Agreement shall in all cases be construed as a whole according to its fair meaning, and not strictly for or against any of the parties.
(b) As used in this Separation Agreement, the term “or” shall be deemed to include the term “and/or” and the singular or plural number shall be deemed to include the other whenever the context so indicates or requires.
(c) The paragraph headings used in this Separation Agreement are intended solely for convenience of reference and shall not in any manner amplify, limit, modify or otherwise be used in the interpretation of any of the provisions hereof.
(d) The parties also agree that the terms of this Separation Agreement were reached following arms-length negotiations and shall not be construed against the drafter in any respect.
8
19. Amendments.
This Separation Agreement may be modified, altered or terminated only by an express written agreement between Unigene and Employee which agreement must be signed by both parties or their duly authorized agents, and expressly reference and attach a copy of this Separation Agreement in order to be effective.
20. Entire Agreement.
This Separation Agreement comprises the entire agreement between Employee and the Company and fully supersedes any and all prior agreements or understandings between the parties pertaining to its subject matter.
IN WITNESS WHEREOF, intending to be forever legally bound hereby, the parties have executed this Separation Agreement, being twelve (12) pages in total length plus its Acknowledgment Page, on the dates set forth below:
| Dated: August 13, 2012 | /s/ Jenene Thomas | ||
|
|
|
||
|
Jenene Thomas
|
|||
|
Unigene Laboratories, Inc.
|
|||
| Dated: August 13, 2012 | By: | /s/ Pamela Cantor | |
|
Pamela Cantor
|
|||
|
Vice President, Human Resources
|
|||
|
and Business Administration
|
|||
9
ACKNOWLEDGMENT
STATE OF New Jersey )
) SS.:
COUNTY OF Hunterdon )
On this 13 day of August, 2012, before me, the subscriber, a notary public in and for the above County and State, appeared Jenene Thomas, known and identified to me to be the person described herein, and executed the foregoing Confidential Separation Agreement and General Release, consisting of thirteen (13) pages (including this Acknowledgment Page), duly acknowledging to me that her execution of same was knowing and voluntary and that she signed the same as her own free act and deed for the uses and purposes therein mentioned.
IN WITNESS WHEREOF, I have hereunto set my hand and seal at in person, the day and year aforesaid.
| SEAL | /s/ Justin Romanowski | |
|
NOTARY PUBLIC
|
||
| [Seal of Justin E. Romanowski | ||
| Notary Public | ||
| State of New Jersey | ||
| My Commision expires Jan 30, 2013] |
10